Literature DB >> 12201993

Composition options for tissue-engineered bone.

Janine M Orban1, Kacey G Marra, Jeffrey O Hollinger.   

Abstract

The logical assembly of tissue-engineered bone is ultimately directed by the clinical status of the patient. The basic elements for tissue-engineered bone should include signaling molecules, cells, and extracellular matrix. The assembly of these basic elements may need to be modified by tissue engineers to account for patient variables of age, gender, health, systemic conditions, habits, and anatomical implant. Moreover, different regions of the body will have different functional loads and vascularity. This review discusses several basic options that may be necessary to engineer bone, including spatial and temporal assembly of signaling factors, cells, and biomimetic extracellular matrices. Moreover, the importance of the health care status of the patient who may be receiving the tissue-engineered composition is emphasized.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 12201993     DOI: 10.1089/107632702760240454

Source DB:  PubMed          Journal:  Tissue Eng        ISSN: 1076-3279


  13 in total

1.  Low level laser irradiation stimulates osteogenic phenotype of mesenchymal stem cells seeded on a three-dimensional biomatrix.

Authors:  Liat Abramovitch-Gottlib; Talia Gross; Doron Naveh; Shimona Geresh; Salman Rosenwaks; Ilana Bar; Razi Vago
Journal:  Lasers Med Sci       Date:  2005-11-16       Impact factor: 3.161

2.  Calcium phosphate deposition rate, structure and osteoconductivity on electrospun poly(l-lactic acid) matrix using electrodeposition or simulated body fluid incubation.

Authors:  Chuanglong He; Xiaobing Jin; Peter X Ma
Journal:  Acta Biomater       Date:  2013-09-05       Impact factor: 8.947

Review 3.  Building bridges: leveraging interdisciplinary collaborations in the development of biomaterials to meet clinical needs.

Authors:  Eliza L S Fong; Brendan M Watson; F Kurtis Kasper; Antonios G Mikos
Journal:  Adv Mater       Date:  2012-07-23       Impact factor: 30.849

4.  Ethyl-3,4-dihydroxybenzoate with a dual function of induction of osteogenic differentiation and inhibition of osteoclast differentiation for bone tissue engineering.

Authors:  Byeong-Ju Kwon; Mi Hee Lee; Min-Ah Koo; Jae-Jin Han; Jong-Chul Park
Journal:  Tissue Eng Part A       Date:  2014-06-23       Impact factor: 3.845

Review 5.  Microfabricated biomaterials for engineering 3D tissues.

Authors:  Pinar Zorlutuna; Nasim Annabi; Gulden Camci-Unal; Mehdi Nikkhah; Jae Min Cha; Jason W Nichol; Amir Manbachi; Hojae Bae; Shaochen Chen; Ali Khademhosseini
Journal:  Adv Mater       Date:  2012-03-13       Impact factor: 30.849

6.  Three-Dimensional Porous Trabecular Scaffold Exhibits Osteoconductive Behaviors In Vitro.

Authors:  Brittany L Taylor; Xiomara I Perez; James Ciprano; Chinyere Onyekachi Utaegbulam Freeman; Aaron Goldstein; Joseph Freeman
Journal:  Regen Eng Transl Med       Date:  2019-12-11

7.  Osteogenic differentiation of mesenchymal stem cells in defined protein beads.

Authors:  Amanda W Lund; Jeff A Bush; George E Plopper; Jan P Stegemann
Journal:  J Biomed Mater Res B Appl Biomater       Date:  2008-10       Impact factor: 3.368

Review 8.  Nanotechnology in bone tissue engineering.

Authors:  Graham G Walmsley; Adrian McArdle; Ruth Tevlin; Arash Momeni; David Atashroo; Michael S Hu; Abdullah H Feroze; Victor W Wong; Peter H Lorenz; Michael T Longaker; Derrick C Wan
Journal:  Nanomedicine       Date:  2015-03-16       Impact factor: 5.307

9.  Effects of polycaprolactone-tricalcium phosphate, recombinant human bone morphogenetic protein-2 and dog mesenchymal stem cells on bone formation: pilot study in dogs.

Authors:  Sun-Jong Kim; Myung-Rae Kim; Jin-Sub Oh; Inho Han; Sang-Wan Shin
Journal:  Yonsei Med J       Date:  2009-12-18       Impact factor: 2.759

10.  In vitro and in vivo effects of rat kidney vascular endothelial cells on osteogenesis of rat bone marrow mesenchymal stem cells growing on polylactide-glycoli acid (PLGA) scaffolds.

Authors:  Hongchen Sun; Zhe Qu; Ying Guo; Guangxiang Zang; Bai Yang
Journal:  Biomed Eng Online       Date:  2007-11-04       Impact factor: 2.819

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.